BenchSci raises $70m in Series D for AI-powered drug discovery solutions
BenchSci, a provider of artificial intelligence (AI) solutions for preclinical life sciences research and development (R&D), has successfully raised CAD 95 million ($70 million) in a Series D funding round. The latest funding round was led by Generation Investment Management, with participation from existing investors including iNovia Capital, Golden Ventures, TCV, and F-Prime Capital. With […]